raloxifene hydrochloride has been researched along with Hyperparathyroidism, Secondary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farbodara, T; Haghverdi, F; Mortaji, S; Saidi, N; Soltani, P | 1 |
1 trial(s) available for raloxifene hydrochloride and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5.
Topics: Administration, Oral; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |